Uranium Royalty Corp. (NASDAQ:UROY) Reduces -13.01% In A Week: What’s Taking The Stock Higher?

In last trading session, Uranium Royalty Corp. (NASDAQ:UROY) saw 1.16 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $3.61 trading at -$0.24 or -6.23% at ring of the bell on the day assigns it a market valuation of $282.76M. That closing price of UROY’s stock is at a discount of -55.12% from its 52-week high price of $5.60 and is indicating a premium of 77.56% from its 52-week low price of $0.81. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.15 million shares which gives us an average trading volume of 614.98K if we extend that period to 3-months.

For Uranium Royalty Corp. (UROY), analysts’ consensus is at an average recommendation of a Buy. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell […]

About the author: StockMan
Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.
Posting Guidelines
Do
  • Do contribute something to the discussion
  • Do post factual information, analysis and your view on company valuations
  • Do disclose if you have an interest in a security
  • Do take our Terms of Use seriously
Do Not
  • Do not make low-content posts, unsubstantiated ramps or untruthful/misleading statements
  • Do not complain about a post unless you have reported it first, and not on the forum.
  • Do not post financial advice
  • Do not advertise or post sponsored content

Get involved!

Get Connected!

Come and join our community. Expand your network and get to know new people!

Comments

No comments yet